04 Sep 2018
Researchers at the University of Dundee have identified a new drug target in parasites that cause major neglected tropical diseases, a discovery that contributes towards a global drive to eliminate these diseases by 2030.
25 Jul 2018
A new preclinical candidate drug with the potential to treat visceral leishmaniasis, one of the world’s major neglected diseases, has been discovered through a close collaboration between the University of Dundee, GSK and Wellcome.
10 Jul 2018
The African trypanosome causes African sleeping sickness, a hideous disease transmitted by the tsetse fly that, untreated, leads to character disintegration, comma and death. The trypanosome parasite evades the patient’s immune system by ‘antigenic variation’, which is the swapping one protective surface coat for another.
12 Jun 2018
A new study entitled “Proteomic Analysis of the Cell Cycle of Procylic Form Trypanosoma brucei” has just been published in Molecular and Cellular Proteomics (Crozier et al., 2018, Mol Cell Proteomics 2018 17: 1184-1195). This study resulted from a collaboration between the laboratories of Mike Ferguson (BCDD) and Angus Lamond (GRE). Trypanosoma brucei is an evolutionarily divergent eukaryotic protozoan parasite that causes human and animal trypanosomiasis (also called ‘sleeping sickness’) in sub-Saharan Africa.
31 May 2018
Scientists from the University of Dundee will swap lab coats for hiking boots this weekend as they take on one of Scotland’s greatest wildlife trails for charity. A team of four scientists from the University’s School of Life Sciences, hope to finish the 52 mile Cateran Trail within just five days as they aim to raise funds for Cats Protection and Re-Act Scotland.
02 May 2018
At the Wellcome Centre for Anti-Infectives Research, we have made an exciting discovery about a group of life-threatening parasites.
16 Apr 2018
An exciting new long-term collaboration has been launched between Dundee Rep Theatre and the School's Wellcome Centre for Anti-Infectives Research where together they will develop a series of innovative and diverse engagement and performance opportunities for local communities.
DNDi, GlaxoSmithKline, and University of Dundee to identify drug candidates to treat leishmaniasis...02 Apr 2018
The Drug Discovery Unit (DDU) will collaborate with the not-for-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) and GlaxoSmithKline (GSK) in a bid to discover new pre-clinical drug candidates targeting two parasitic neglected tropical diseases (NTDs), leishmaniasis and Chagas disease.
17 Jan 2018
Kevin Read and Simon Arthur have been promoted to Personal Chair (Professor) as part of the 2017 Annual Review process for academic staff. Kevin Read will become Professor of Quantitative Pharmacology while Simon Arthur will be Professor of Immune Signalling. “I would like to congratulate both Kevin and Simon on their well-deserved promotions,” said Professor Julian Blow, Dean of Research in the School of Life Sciences. “Both have made significant contributions to their respective fields over a sustained period of time as well as contributing to teaching our undergraduates.”
18 Dec 2017
Dr. Mattie Christine Pawlowic has opened a new research laboratory jointly in the Division of Biological Chemistry and Drug Discovery (BCDD) and our new Wellcome Centre for Anti-Infectives Research (WCAIR).